GENES OVEREXPRESSED BY OVARIAN CANCER AND THEIR USE IN DEVELOPING NOVEL THERAPEUTICS

Details for Australian Patent Application No. 2003253632 (hide)

Owner IDEC PHARMACEUTICALS CORPORATION

Inventors HARIHARAN, Kandasamy; DANIELS, Mark; MCLACHLAN, Karen

Pub. Number AU-A-2003253632

PCT Number PCT/US03/18253

PCT Pub. Number WO2003/104429

Priority 60/386,748 10.06.02 US; 60/396,141 17.07.02 US; 60/405,319 23.08.02 US; 60/428,274 22.11.02 US

Filing date 10 June 2003

Wipo publication date 22 December 2003

Event Publications

30 October 2003 Complete Application Filed

  Priority application(s): 60/386,748 10.06.02 US; 60/396,141 17.07.02 US; 60/405,319 23.08.02 US; 60/428,274 22.11.02 US

19 February 2004 Application Open to Public Inspection

  Published as AU-A-2003253632

28 April 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003253633-SUPPRESSION OF METHANATION ACTIVITY OF PLATINUM GROUP METAL WATER-GAS SHIFT CATALYSTS

2003253631-DATA PROCESSOR ADAPTED FOR TURBO DECODING